Cardiac progression of systemic light chain amyloidosis
DOI:
https://doi.org/10.47487/apcyccv.v3i4.249Keywords:
Inmunoglobulin Light-chain Amyloidosis, Heart Failure, Cardiomyopathies, Electrocardiography, EchocardiographyAbstract
Systemic light chain amyloidosis is a disease characterized by the accumulation of amyloid protein in multiple organs and systems. We present the case of a 52-year-old male patient with a diagnosis of systemic light chain amyloidosis associated with cardiac and renal involvement. A renal biopsy showed the presence of renal amyloidosis associated with proteinuria, and the patient was referred for cardiovascular evaluation. The baseline electrocardiogram showed micro voltage in frontal leads that were discordant with the left ventricular hypertrophy evidenced in the transthoracic echocardiogram (TTE). Cardiac magnetic resonance imaging (CMR) confirmed the presence of cardiac amyloid infiltration with a pattern of extensive ventricular late-gadolinium enhancement. Despite being referred and receiving specific systemic chemotherapy treatment, the evolution was not favorable after four months of follow-up with worsening cardiac infiltration, increasing values of biomarkers, and progression of dyspnea. The TTE was useful in revealing the unfavorable evolution and worsening of diastolic function parameters and increased wall thickness in the context of infiltration. The electrocardiogram and echocardiogram were easily accessible tools that allowed the monitoring of the response to treatment.
Downloads
References
Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol. 2015;24(6):343-50. doi: 10.1016/j.carpath.2015.07.008.
Clemmensen TS, Eiskjær H, Ladefoged B, Mikkelsen F, Sørensen J, Granstam SO, et al. Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2021;22(6):695-704. doi: 10.1093/ehjci/jeaa097.
Olea-sánchez EG, Sánchez-moreno EC, Ramón D, Valencia-lópez R, Luque-hernández A. Síndrome nefrótico por
amiloidosis AL asociado con gammapatia monoclonal de cadenas ligeras lambda Nephrotic syndrome by amyloidosis
AL associated to lambda light-chain monoclonal. Med Interna México. 2020;36(5):722-6. doi:10.24245/mim.v36i5.3236.
Castillo-Velarde ER. Amiloidosis primaria. Rev la Fac Med Humana. 2019;19(3):81-5. doi: 10.25176/RFMH.v19i3.2151.
Magro Checa C, Rosales Alexander JL, Salvatierra J, Raya Álvarez E. Amyloidosis. Med. 2013;11(34):2065-
doi:10.1016/S0304-5412(13)70581-X.
Lazo-Soldevilla M, Meza- Centeno L, Santos-Julca C, Maita-Hinostroza R. Miocardiopatía por amiloidosis: una causa
imprevista de accidente cerebrovascular. Rev la Soc Peru Med Interna. 2022;35(1):37-40. doi:10.36393/spmi.v35i1.655
Liao R, Jain M, Teller P, Connors LH, Ngoy S, Skinner M, et al. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 2001 Oct 2;104(14):1594-7. Erratum in: Circulation. 2013 Sep 10;128(11):e174.
Muñoz Moreno JM, Añorga Ocmin J, Espinola García S, Aguilar C, Alarco W. Amiloidosis cardíaca: Experiencia en un Instituto Cardiovascular de referencia nacionaI. Arch Peru Cardiol y Cirugía Cardiovasc. 2020;1(2):95-104. doi: 10.47487/apcyccv.v1i2.40.
Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging.
;13(6):1368-83. doi: 10.1016/j.jcmg.2019.07.015.
Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42(16):1554-1568. doi: 10.1093/eurheartj/ehab072.
Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442-8. doi: 10.1136/heartjnl-2012-302353.
Peña C, González JT, López-Vidal H, Donoso J, Contreras C, Vergara CG, et al. AL amyloidosis in the Chilean public health system: A pending debt. Multicenter study of the Chilean Monoclonal Gammopathies Cooperative Group.
Rev Med Chil. 2019;147(10):1239-46. doi: 10.4067/s0034-98872019001001239.
Cyrille NB, Goldsmith J, Alvarez J, Maurer MS. Prevalence and prognostic significance of low QRS voltage among
the three main types of cardiac amyloidosis. Am J Cardiol. 2014;114(7):1089-93. doi: 10.1016/j.amjcard.2014.07.026.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 The journal is headline of the first publication, then the author giving credit to the first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License.